$PFE Headlines Pfizer a buy after merger talks break

New Post Public Reply Private Reply Replies (0) Message Board

Jun 2, 2014 at 3:02 PM

$PFE Headlines

Pfizer a buy after merger talks break down: Goldman 11:12 a.m. May 28, 2014 - Ben Eisen
Stay tuned for more drama in Pfizer-AstraZeneca saga, analysts say 3:15 p.m. May 27, 2014 - blogs.marketwatch.com
U.K. stocks up as InterContinental jumps amid bid talk 12:52 p.m. May 27, 2014 - Carla Mozee
European stocks gain, but AstraZeneca slumps 12:18 p.m. May 27, 2014 - Carla Mozee
Is the fate of the stock market in the IRS’s hands? 11:33 a.m. May 27, 2014 - Simon Constable
Newscast: Wall Street continues to gain ground 9:58 a.m. May 27, 2014 - MarketWatch
Newscast: Pfizer walks away from AstraZeneca 7:31 a.m. May 27, 2014 - MarketWatch
Pfizer walks away from AstraZeneca deal 4:02 a.m. May 27, 2014 - Geoffrey Rogow
AstraZeneca boosts FTSE 100 after two days in red 12:28 p.m. May 21, 2014 - Sara Sjolin
AstraZeneca shares creep back up amid urges to reconsider Pfizer deal 12:15 p.m. May 21, 2014 - blogs.marketwatch.com
5 value stocks for investors who fear the worst 10:14 a.m. May 21, 2014 - Philip van Doorn
The best thing about Pfizer’s failure with AstraZeneca 4:00 a.m. May 21, 2014 - Matthew Lynn
U.S. stocks gain as Apple, Russell 2000 rise 1% 5:03 p.m. May 19, 2014 - Anora Mahmudova
Newscast: Stocks open week with a win 4:33 p.m. May 19, 2014 - MarketWatch
Apple reclaims $600 mark; AT&T down on DirecTV deal 3:37 p.m. May 19, 2014 - Saumya Vaishampayan
Stocks rise for second day; small-caps, tech lead: Stock market live blog recap 3:31 p.m. May 19, 2014 - blogs.marketwatch.com
Who can afford AstraZeneca's asking price? Not many, analysts say 2:18 p.m. May 19, 2014 - blogs.marketwatch.com
Investors welcome Pfizer's latest rejection 12:34 p.m. May 19, 2014 - MarketWatch
FTSE 100 yanked lower by AstraZeneca, miners 12:31 p.m. May 19, 2014 - Sara Sjolin
AstraZeneca weighs on Stoxx 600 after rebuffing Pfizer 12:20 p.m. May 19, 2014 - Sara Sjolin

Mylan settles Celebrex patent suit 1:30 p.m. Today - Seeking Alpha
3 Stocks Advancing The Drugs Industry 1:03 p.m. Today - TheStreet.com
7 Stocks That Will Lift the Dow Jones Industrial Average to New High 12:33 p.m. Today - TheStreet.com
3 Stocks Reiterated As A Buy: PFE, UNH, OXY 9:59 a.m. Today - TheStreet.com
Today's Market: Shareholders To Push For Change At These Companies? 9:25 a.m. Today - Seeking Alpha
Mylan, Pfizer Settle on Generic Celebrex 7:44 a.m. Today - The Wall Street Journal Interactive Edition
Drug Firms Target Smaller Deals 7:21 a.m. Today - The Wall Street Journal Interactive Edition
Retirement Strategy: ETF Portfolio Vs. The Stock Only Portfolio: Surprise, Surprise! 7:30 a.m. May 31, 2014 - Seeking Alpha
When Fraud Bites Business: Lost Fortunes, Reputations and Lives 10:30 p.m. May 30, 2014 - InvestorPlace.com
Dividend Stocks Vs. Junk Bond Yields 3:32 p.m. May 30, 2014 - Seeking Alpha
Court Backs Exclusive Period for Teva's Generic Celebrex Sales 1:33 p.m. May 30, 2014 - The Wall Street Journal Interactive Edition
Dow 30 Stock Roundup: Pfizer Scraps Astrazeneca Deal, CVX Production Growth on Track - Analyst Blog 11:19 a.m. May 30, 2014 - Zacks.com
Top 10 Dow Dividend Stocks for May 10:21 a.m. May 30, 2014 - InvestorPlace.com
Teva gets favorable court ruling on generic Celebrex 9:28 a.m. May 30, 2014 - Seeking Alpha
Pfizer: Why A Major Acquisition Or Break-Up Is Needed 8:47 a.m. May 30, 2014 - Seeking Alpha
Elelyso gets the nod in Canada 7:52 a.m. May 30, 2014 - Seeking Alpha
Actavis, Forest CEOs Team Up To Lead New Drug Giant 3:47 p.m. May 29, 2014 - Investors Business Daily
Sanofi-Eli Lilly Collaborate for OTC Cialis - Analyst Blog 1:50 p.m. May 29, 2014 - Zacks.com
Dow Today: Pfizer (PFE) Higher 11:00 a.m. May 29, 2014 - TheStreet.com
IHG Faces Pressure to Seek Merger 9:38 a.m. May 29, 2014 - The Wall Street Journal Interactive Edition

Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. Today - PR Newswire - PRF
Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research 11:14 a.m. May 29, 2014 - BusinessWire - BZX
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development 8:30 a.m. May 29, 2014 - BusinessWire - BZX
ACETO Subsidiary, Rising Pharmaceuticals, Has Launched the Generic Version of Pfizer Inc.'s Diflucan(R) 4:06 p.m. May 27, 2014 - GlobeNewswire
Must Watch News: Pfizer Inc, AT&T, Alpha Natural Resources, Sprint Corporation 9:06 a.m. May 27, 2014 - ACCESSWIRE
Pfizer BringsFrequent Heartburn ReliefOver-the-Counter with New Nexium® 24HR 8:31 a.m. May 27, 2014 - BusinessWire - BZX
Favorable Support, NDA Submission, Conference Schedule, Acquisition Update, and Executive Appointment - Analyst Notes on Allergan, Pfizer, Eli Lilly, Forest and Pharmacyclics 7:20 a.m. May 27, 2014 - PR Newswire - PRF
Statement from Pfizer Inc. 10:05 a.m. May 26, 2014 - BusinessWire - BZX
Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis 9:13 a.m. May 23, 2014 - BusinessWire - BZX
BioRestorative Therapies Signs Research Agreement with Pfizer Inc. 8:01 a.m. May 22, 2014 - BusinessWire - BZX
Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 11:59 a.m. May 21, 2014 - PR Newswire - PRF
Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 11:40 a.m. May 21, 2014 - PR Newswire - PRF
New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace 8:15 a.m. May 21, 2014 - BusinessWire - BZX
GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial 4:01 p.m. May 20, 2014 - BusinessWire - BZX
Statement from Pfizer Inc. 6:41 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Completes Acquisition of Fabrus 8:31 a.m. May 19, 2014 - BusinessWire - BZX
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index 8:05 a.m. May 19, 2014 - GlobeNewswire
Pfizer Makes Final Proposal to AstraZeneca 5:03 p.m. May 18, 2014 - BusinessWire - BZX
Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 12:12 p.m. May 16, 2014 - BusinessWire - BZX
FDA Approvals, Stock Price Updates, and Financial Results Release - Analyst Notes on Pfizer, Actavis, Pharmacyclics, Mallinckrodt and Salix Pharmaceuticals 7:40 a.m. May 16, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kimley-Horn Shines as Top Workplace for Women Again

A Legacy of Workplace Excellence When you've been around the block as much as I have, you come to realize that standing out in the business world takes more than just numbers on a balance sheet—it takes heart, and maybe a bit of luck. That's why seeing Kimley-Horn bag the No. 13 spot on the Fortune Best Workplaces for Women list for the 10th time is something to raise...

Life Time's Q3 2026 Results Highlight Solid Growth

Life Time Rolls On With Strong Q3 Performance Sometimes the market hands you pure gold, and that's what Life Time (NYSE: LTH) has right now. They didn't just have a decent quarter; they outright nailed it with a $893.5 million total revenue haul—a hefty 14.2% rise from the prior year. What's driving this ship? Solid growth in membership dues and dynamic personal...

Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Mausam Bhatt Joins Cars.com as Chief Product Officer

Shifting Gears with a New Leader Sometimes the name alone isn't enough to get things rolling, but when someone who's built billion-dollar platforms from scratch joins your team, the engine's ready to roar. That's the motor firing up at Cars.com with Mausam Bhatt behind the wheel as their fresh Chief Product Officer. If you think a new set of eyes can only see what's...

MetroScape: Local Roots Fuel Bold DFW Growth Plans

A Local Business with Big Aspirations Here's the deal, folks: Local guys Dr. Marc Nickell and Chris Brewer snatched up MetroScape Landscape like it was the last slice of grandma's pie. Why? Not just for the greenbacks—they're putting down roots in their very own backyard, the Dallas-Fort Worth area. What Does Local Really Mean? Look, it's one thing hitting up a...

ESI Motion's Role in Lockheed's Missile Defense Program

ESI Motion's Solar Drive Tech Joins the Defense Arena Picture this: ESI Motion Inc. just inked a deal with Lockheed Martin to supply Solar Array Drive Electronics (SADE) technology—a serious move in space tech. Now, ESI isn't just playing in the local Simi Valley sandbox; they're thrusting their tech into something much more critical—national defense. We're talking...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Navigate360 Data Breach Concerns: Legal Insights

No Safety in a Storm: Navigate360's Data Breach Fiasco When you think of data breaches, you often envision some shady hacker in a hoodie, but here we are with Navigate360 losing control of a massive chunk of sensitive data involving school safety tips. You'd hope companies with serious access to personal information are better at keeping secrets, right? Yet, here we are,...

N? KOA's 11-Year Journey: From Art to Legacy

N? KOA: Leather Meets Polynesian Tattoo Art N? KOA, the Hawaii-based leather goods brand, knows a thing or two about weaving art into tradition. Eleven years back, they took the plunge with a compact line of men's bifold wallets, featuring designs by just three talented Polynesian tattoo artists. Today, that tribe's grown to 16 artists from across the Pacific, each...